$DUKR

2023 Q3 Form 10-Q Financial Statement

#000121390023064050 Filed on August 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $173.0K $206.0K $223.0K
YoY Change -22.42% -37.0% 106.48%
% of Gross Profit
Research & Development $0.00 $0.00
YoY Change -100.0% -100.0%
% of Gross Profit
Depreciation & Amortization $6.000K $0.00
YoY Change 500.0% -100.0%
% of Gross Profit
Operating Expenses $173.0K $0.00 $223.0K
YoY Change 1472.73% -100.0% 108.41%
Operating Profit -$173.0K -$206.0K
YoY Change -26.07% -37.58%
Interest Expense $23.00K $23.00K $16.00K
YoY Change -675.0% -46.51% -90.75%
% of Operating Profit
Other Income/Expense, Net $23.00K
YoY Change
Pretax Income -$150.0K -$183.0K -$207.0K
YoY Change -36.97% -36.24% -413.64%
Income Tax
% Of Pretax Income
Net Earnings -$150.0K -$183.0K -$207.0K
YoY Change -36.97% -36.24% -413.64%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 54.22M shares 54.22M shares 54.22M shares
Diluted Shares Outstanding 54.56M shares 54.56M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.358M $2.849M
YoY Change -21.66% -19.97%
Cash & Equivalents $2.358M $2.419M $2.849M
Short-Term Investments
Other Short-Term Assets $285.0K $258.0K $86.00K
YoY Change 691.67% 396.15% 115.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.643M $2.677M $2.935M
YoY Change -13.23% -16.5% -18.47%
LONG-TERM ASSETS
Property, Plant & Equipment $52.00K $54.00K $42.00K
YoY Change 136.36% 134.78% 366.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $128.0K $15.00K
YoY Change 753.33%
Total Long-Term Assets $180.0K $194.0K $57.00K
YoY Change 386.49% 410.53% 533.33%
TOTAL ASSETS
Total Short-Term Assets $2.643M $2.677M $2.935M
Total Long-Term Assets $180.0K $194.0K $57.00K
Total Assets $2.823M $2.871M $2.992M
YoY Change -8.43% -11.5% -17.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $82.00K $77.00K $85.00K
YoY Change -5.75% 0.0% 13.33%
Accrued Expenses $50.00K $176.0K
YoY Change -50.5% 29.41%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $452.0K $358.0K $261.0K
YoY Change 140.43% 104.57% 23.7%
LONG-TERM LIABILITIES
Long-Term Debt $311.0K $305.0K
YoY Change 2.64% 2.69%
Other Long-Term Liabilities $54.00K
YoY Change
Total Long-Term Liabilities $365.0K $305.0K
YoY Change 20.46% 2.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $452.0K $358.0K $261.0K
Total Long-Term Liabilities $365.0K $305.0K
Total Liabilities $817.0K $734.0K $566.0K
YoY Change 66.4% 54.2% 11.42%
SHAREHOLDERS EQUITY
Retained Earnings -$9.528M -$9.378M -$9.016M
YoY Change 37.83% 40.49% 49.79%
Common Stock $5.000K $5.000K $5.000K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.006M $2.137M $2.426M
YoY Change
Total Liabilities & Shareholders Equity $2.823M $2.871M $2.992M
YoY Change -8.43% -11.5% -17.1%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q4
OPERATING ACTIVITIES
Net Income -$150.0K -$183.0K -$207.0K
YoY Change -36.97% -36.24% -413.64%
Depreciation, Depletion And Amortization $6.000K $0.00
YoY Change 500.0% -100.0%
Cash From Operating Activities -$260.0K -$152.0K
YoY Change 80.56% -10.59%
INVESTING ACTIVITIES
Capital Expenditures $2.000K $20.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$2.000K -$5.000K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -260.0K -152.0K
Cash From Investing Activities -2.000K -5.000K
Cash From Financing Activities 0.000
Net Change In Cash -262.0K -157.0K
YoY Change 81.94% -7.65%
FREE CASH FLOW
Cash From Operating Activities -$260.0K -$152.0K
Capital Expenditures $2.000K $20.00K
Free Cash Flow -$262.0K -$172.0K
YoY Change 81.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55504
dei Entity Registrant Name
EntityRegistrantName
UAS Drone Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-3052410
dei Entity Address Address Line1
EntityAddressAddressLine1
10 HaRimon Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Mevo Carmel Science and Industrial Park
dei Entity Address Country
EntityAddressCountry
IL
dei Entity Address City Or Town
EntityAddressCityOrTown
Israel
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
2069203
dei Local Phone Number
LocalPhoneNumber
+972-4-8124101
dei City Area Code
CityAreaCode
+972
dei Security12b Title
Security12bTitle
N/A
dei Trading Symbol
TradingSymbol
N/A
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
54218813 shares
CY2023Q2 us-gaap Cash
Cash
2419000 usd
CY2022Q4 us-gaap Cash
Cash
2849000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
258000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
86000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
2677000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
2935000 usd
CY2023Q2 us-gaap Deferred Costs Leasing Net Noncurrent
DeferredCostsLeasingNetNoncurrent
140000 usd
CY2022Q4 us-gaap Deferred Costs Leasing Net Noncurrent
DeferredCostsLeasingNetNoncurrent
15000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
54000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42000 usd
CY2023Q2 us-gaap Assets
Assets
2871000 usd
CY2022Q4 us-gaap Assets
Assets
2992000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
77000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
85000 usd
CY2023Q2 usdr Other Accounts Liabilities Current
OtherAccountsLiabilitiesCurrent
281000 usd
CY2022Q4 usdr Other Accounts Liabilities Current
OtherAccountsLiabilitiesCurrent
176000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
358000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
261000 usd
CY2023Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
309000 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
305000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
67000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
734000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
566000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54218813 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54218813 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54218813 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54218813 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11510000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11437000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9378000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9016000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2137000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2426000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2871000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2992000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
408000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
658000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
206000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
327000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-408000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-667000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-206000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-330000 usd
usdr Financing Incomeexpense Net
FinancingIncomeexpenseNet
46000 usd
usdr Financing Incomeexpense Net
FinancingIncomeexpenseNet
11000 usd
CY2023Q2 usdr Financing Incomeexpense Net
FinancingIncomeexpenseNet
23000 usd
CY2022Q2 usdr Financing Incomeexpense Net
FinancingIncomeexpenseNet
43000 usd
us-gaap Net Income Loss
NetIncomeLoss
-362000 usd
us-gaap Net Income Loss
NetIncomeLoss
-656000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-183000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-287000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54521506 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54076824 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54556313 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54118813 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2426000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
39000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-179000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2286000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
34000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-183000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2137000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3101000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
180000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-369000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2912000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
143000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-287000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2768000 usd
us-gaap Net Income Loss
NetIncomeLoss
-362000 usd
us-gaap Net Income Loss
NetIncomeLoss
-656000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
73000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
323000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-4000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-4000 usd
usdr Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-20000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-28000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
166000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
12000 usd
us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
-8000 usd
us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
2000 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
53000 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-38000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-410000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-376000 usd
usdr Lease Deposit
LeaseDeposit
15000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
-4000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-430000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-406000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2849000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3560000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2419000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3154000 usd
usdr Initial Recognition Of Operating Lease Rightofuse Assets
InitialRecognitionOfOperatingLeaseRightofuseAssets
146000 usd
usdr Initial Recognition Of Operating Lease Liability
InitialRecognitionOfOperatingLeaseLiability
146000 usd
CY2020Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
0.0001
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 49.6pt"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 49.6pt">The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, certain revenues and expenses, and disclosure of contingent assets and liabilities as of the date of the financial statements. Actual results could differ from those estimates. As applicable to these unaudited condensed financial statements, the most significant estimates and assumptions relate to the share based compensation.</p>
CY2022Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P3Y
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
4600 usd
CY2022Q2 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
4800 usd
CY2022Q2 us-gaap Loans And Leases Receivable Commitments Fixed Rates
LoansAndLeasesReceivableCommitmentsFixedRates
15000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
14000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
23000 usd
us-gaap Operating Leases Income Statement Initial Direct Costs
OperatingLeasesIncomeStatementInitialDirectCosts
146000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
126000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
51000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
67000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
118000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0875 pure
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
27000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
54000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
51000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
132000 usd
CY2023Q2 us-gaap Receivable With Imputed Interest Net Amount
ReceivableWithImputedInterestNetAmount
14000 usd
CY2023Q2 us-gaap Short Term Lease Commitment Amount
ShortTermLeaseCommitmentAmount
118000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2426812 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.81
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2426812 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.81
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1592747 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.96
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
45000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
0.1
CY2023Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
2426812 shares
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y9M10D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1592747 shares
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
2426812 shares
CY2022 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P4Y3M10D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1387092 shares
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
73000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
34000 usd
usdr Directors Compensation
DirectorsCompensation
201000 usd
usdr Directors Compensation
DirectorsCompensation
282000 usd
CY2023Q2 usdr Directors Compensation
DirectorsCompensation
94000 usd
CY2022Q2 usdr Directors Compensation
DirectorsCompensation
130000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
104000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
4000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
4000 usd
CY2023Q2 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2000 usd
CY2022Q2 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2000 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
37000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
35000 usd
CY2023Q2 us-gaap Loans Payable
LoansPayable
309000 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
305000 usd
usdr Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
usd
usdr Initial Recognition Of Operating Lease Rightofuse Assets
InitialRecognitionOfOperatingLeaseRightofuseAssets
usd
usdr Initial Recognition Of Operating Lease Liability
InitialRecognitionOfOperatingLeaseLiability
usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
usd
us-gaap Operating Leases Income Statement Initial Direct Costs
OperatingLeasesIncomeStatementInitialDirectCosts
usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
pure
usdr Share Based Compensation Arrangement By Share Based Payment Award Options Exercise In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExerciseInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2022Q4 usdr Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001638911

Files In Submission

Name View Source Status
0001213900-23-064050-index-headers.html Edgar Link pending
0001213900-23-064050-index.html Edgar Link pending
0001213900-23-064050.txt Edgar Link pending
0001213900-23-064050-xbrl.zip Edgar Link pending
f10q0623ex31-1_uasdrone.htm Edgar Link pending
f10q0623ex31-2_uasdrone.htm Edgar Link pending
f10q0623ex32-1_uasdrone.htm Edgar Link pending
f10q0623ex32-2_uasdrone.htm Edgar Link pending
f10q0623_uasdrone.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
f10q0623_uasdrone_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usdr-20230630.xsd Edgar Link pending
usdr-20230630_def.xml Edgar Link unprocessable
usdr-20230630_lab.xml Edgar Link unprocessable
usdr-20230630_pre.xml Edgar Link unprocessable
usdr-20230630_cal.xml Edgar Link unprocessable